Premenstrual syndrome

Trends in Endocrinology and Metabolism

Volumn 7, Issue 5, 1996, Pages 184-189

  Mortola, Joseph F ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ALPRAZOLAM; CONJUGATED ESTROGEN; ESTROGEN; FLUOXETINE; GONADORELIN AGONIST; GONADORELIN DERIVATIVE; IMIPRAMINE; MEDROXYPROGESTERONE ACETATE; NEUROTRANSMITTER; OPIATE; PROGESTERONE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

CLINICAL TRIAL; DIET; DRUG EFFICACY; ESTROGEN BLOOD LEVEL; FEMALE; HEADACHE; HUMAN; NAUSEA; NERVOUSNESS; NONHUMAN; NUTRITION; PERSONALITY; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; REVIEW; STRESS;

EID: 0030200772     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/1043-2760(96)00060-4     Document Type: Short Survey

References (53)

1. Abraham GE: 1980. Premenstrual tension. Curr Probl Obstet Gynecol 3:12-21.
2. Allen SS, McBride CM, Pirie PL: 1991. The shortened premenstrual assessment form. J Reprod Med 36:769-772.
3. American Psychiatric Association: 1987. American Psychiatric Association, Committee on Nomenclature and Statistics: Diagnostic and Statistical Manual of Mental Disorders, Ed III-R. Washington, D.C., American Psychiatric Association.
4. Andersch B, Abrahamsson K: 1979. Hormone profile in premenstrual tension: effects of bromocriptine and diuretics. Clin Endocrinol 11:657-664.
5. Ashby CR, Carr LA, Cook CL, et al.: 1988. Alteration of platelet serotonin mechanisms and monoamine oxidase activity in premenstrual syndrome. Biol Psychiatry 24:225-231.
6. Beck L, Girvertz R, Mortola JF: 1990. The predictive role of psychosocial stress on symptom severity in premenstrual syndrome. Psychosom Med 52:536-543.
7. Biegan A, Borcovitz H, Samuel D: 1980. Serotonin receptor concentration during the oestrus cycle of the rat. Brain Res 187:221-225.
8. Brown CS, Ling FW, Anderson RN, Farmer RG, Arheart KL: 1994. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptoms severity and type in a controlled clinical trial. Obstet Gynecol 84:779-786.
9. Cedarbaum JM, Aghajanian GK: 1976. Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by the antagonist piperozane. Brain Res 112:413-417.
10. Christie MJ, Chester GB: 1982. Physical dependence on physiologically released endogenous opiates. Life Sci 30:1173-1177.
11. Chuong CJ, Dawson EB: 1992. Critical evaluation of nutritional factors in the pathosphysiology and treatment of premenstrual syndrome. Clin Obstet Gynecol 35:679-692.
12. Chuong CJ, Coulam CB, Koo PC, Gergstralh EJ, Go VLW: 1985. Neuropeptide levels in premenstrual syndrome. Fertil Steril 44:760-765.
13. Endicott J, Halbreich U: 1982. Retrospective report of premenstrual depressive changes: factors affecting confirmation by daily ratings. Psychopharmacol Bull 18:109-112.
14. Endicott J, Halbreich U, Schacht S, Nee J: 1981. Premenstrual changes and affective disorders. Psychosom Med 43:519-529.
15. Gallagher DW: 1978. Benzodiazepines: potentiation of a GABA inhibitory response in the dorsal raphe nucleus. Eur J Pharmacol 49: 133-138.
16. Gold MS, Redmond DE Jr, Kleber HD: 1979. Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal. Am J Psychiatry 136:100-104.
17. Hackman E, Wirz-Justice A, Lichtensteiner M: 1973. Uptake of dopamine and serotonin in the rat brain due to progesterone decline. Psychopharmacologia 4:183-189.
18. 2-adrenergic receptors in rat brain. Nature 291:493-495.
19. Hamilton JA, Parry BL, Alagna S, Blumenthal S, Herz E: 1984. Premenstrual mood changes: a guide to evaluation and treatment. Psychiatr Ann 14:426-435.
20. Harrison WH, Endicott J, Rabkin JG, Nee JC, Sandberg D: 1987. Treatment of premenstrual dysphoria with alprazolam and placebo. Psychopharmacol Bull 23:150-153.
21. Hussan SY, Massil JH, Malta WH, et al.: 1992. Buserelin in premenstrual syndrome. Gynecol Endocrinol 6:57-64.
22. Kleijnen J, Terriel G, Knipschild P: 1991. Vitamin B6 in the treatment of the premenstrual syndrome [review reply]. Br J Obstet Gynaecol 98:3:329.
23. Ladisich W: 1977. Influence of progesterone on serotonin metabolism: a possible causal factor for mood changes. Psychoneuroendocrinology 2:257-266.
24. Lasaga M, Duvilanski BH, Seilicovich A, Afiones S, Dubeljuk L: 1988. Effect of sex steroids on GABA receptors in the rat hypothalamus and anterior pituitary gland. Eur J Pharmacol 155:163-169.
25. Leudo de Tejado A, Carrero QFB, Estela R, et al.: 1978. Elimination urinaria de acido 5-hidroxiindolico durante el cicle menstrual humano. Ginecol Obstet Mex 44:85-94.
26. Majewska MD, Harrison NL, Schwartz RD, et al. 1986: Steroid hormone metabolites are barbiturate like modulators of the GABA receptor. Science 232:1004-1007.
27. Moos RH: 1968. The development of menstrual distress questionnaire. Psychosom Med 30: 853.
28. Morley JE: 1980. The neuroendocrine control of appetite: the role of endogenous opiates, cholecystokinin, TRH, γ-aminobutyric-acid and the diazepam receptor. Life Sci 27:355-362.
29. Mortola JF, Moossazadeh F: 1991. A randomized trial of fluoxetine and impramine in the treatment of premenstrual syndrome [abst]. In Proceedings of the Society for Gynecologic Investigation. Montreal, The Society for Gynecologic Investigation, p 258.
30. Mortola JF, Girton L, Beck L, et al.: 1984. Depressives episodes in premenstrual syndrome. Am J Obstet Gynecol 161:1682-1687.
31. Mortola JF, Beck L, Girton L, et al.: 1989. The temporal delay between ovarian steroid fluctuation and symptoms in premenstrual syndrome [abst 406]. In Proceedings of the Annual Meeting of the Endocrine Society, Washington, DC. Bethesda, MD, The Endocrine Society, p 124.
32. Mortola JF, Girton L, Beck L, Yen SSC: 1990. Diagnosis of premenstrual syndrome by a single, prospective and reliable instrument: the calendar of premenstrual experiences. Obstet Gynecol 76:302-307.
33. Mortola JF, Girton L, Fischer U: 1991. Successful treatment of severe premenstrual syndrome by use of gonadrophin-releasing hormone agonist and estrogen/progestin. J Clin Endocrinol Metab 71:252A-252F.
34. Muse KN, Cetel NS, Futterman LA, Yen SSC: 1984. The premenstrual syndrome: effects of medical ovariectomy. N Engl J Med 311: 1345-1349.
35. Penland JG, Johnson PE: 1993. Dietary calcium and manganese effects on the menstrual cycle. Am J Obstet Gynecol 168:1412-1417.
36. Rapkin A, Chang LH, Reading AE: 1987. Premenstrual syndrome: a double blind placebo controlled study of treatment with progesterone vaginal suppositories. J Obstet Gynecol 7:217-222.
37. Rapkin AJ, Edulmuth E, Chang LC, et al.: 1987. Whole blood serotonin in premenstrual syndrome. Obstet Gynecol 70:533.
38. Reid RL, Yen SSC: 1981. Premenstrual syndrome. Am J Obstet Gynecol 139:85-103.
39. Reid RL, Greenaway-Coates A, Hahn PM: 1986. Oral glucose tolerance during the menstrual cycle in normal women and women with alleged premenstrual "hypoglycemic" attacks: effects of naloxone. J Clin Endocrinol Metab 62:1167-1172.
40. Rosenstein DL, Elin RJ, Hosseini JM, Grover G, Rubinow DW: 1994. Magnesium measurements across the menstrual cycle in premenstrual syndrome. Biol Psychiatry 35:557-561.
41. Schwartz JC, Pollard H, Llorens C, et al.: 1978. Endorphins and endorphin receptors in striatum: relationships with dopaminergic neurons. In Costa E, Trabucchi M, eds. Advances in Biochemistry and Psychopharmacology. New York, Raven, p 245.
42. Smith S, Rinehart JS, Ruddic, VE, Schiff I: 1987. Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial. Obstet Gynecol 70:37-43.
43. Steege JF, Blumenthal JA: 1993. The effects of aerobic exercise on premenstrual stymptoms in middle-aged women: a preliminary study. J Psychosom Res 37:127-133.
44. Steiner M, Steinberg S, Stewart D, et al.: 1995. Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med 332:1529-1534.
45. Stout AL, Steege J: 1985 Psychological assessment of women seeking treatment for premenstrual syndrome. J Psychosom Res 29: 621-629.
46. Tallman JF, Thomas JW, Gallager DW: 1978. GABAergic modulation of benzodiazepine binding site sensitivity. Nature 274:283-285.
47. Taylor D, Matthew RJ, Ho BT: 1982. Serotonin levels and platelet uptake during premenstrual tension. In Proceedings of Serotonin in Biological Psychiatry, 15th Annual Symposium. Hamilton, TX, Texas Research Institute of Mental Sciences, pp 31-47.
48. Taylor RW: 1979. Plasma progesterone, oestradiol 17 beta and premenstrual symptoms. Acta Psychiatr Scand 60:76-86.
49. Wei E, Loh H: 1976. Physical dependence on opiate-like peptides. Science 193:1262-1263.
50. Wirz-Justice A, Chappius Arntt E: 1976. Sex differences in chlorimipramine inhibition of serotonin uptake in human platelets. Eur J Pharmacol 40:21-26.
51. Wood S, Mortola JF, Chan YF, Moosazedeh F, Yen SSC: 1992. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo controlled crossover study. Obstet Gynecol 80:339-344.
52. 3H] opioid receptors in rat brain. J Brain Res 179:255-270.
53. Young WS, Kuhar MJ: 1980. Noradrenergic receptors: light microscopic autoradiographic localization. Proc Natl Acad Sci USA 77:1696-1700.